Yang Zhou is an assistant professor in the department of Molecular Microbiology and Immunology at Brown University. He studies how the immune system is dysregulated and contributes to the pathogenesis of lung injury and repair, in diseases such as pulmonary fibrosis, asthma, pulmonary hypertension, and respiratory infections. His lab uses translational approaches intergrating cell cultures, animal models, human disease samples, as well as computational tools, to identify the molecular and cellular mechanisms that mediate lung injury and repair responses and specific molecular targets that can be targeted in the treatment of related disorders. Dr. Zhou completed a PhD at the University of Texas and a post-doctoral fellowship at Yale University before coming to Brown.
| Gonsalves, Andrea, Sorkhdini, Parand, Bazinet, Jasmine, Ghumman, Moez, Dhamecha, Dinesh, Zhou, Yang, Menon, Jyothi U. "Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery." Biomaterials Advances, vol. 150, 2023, pp. 213430. |
| Hernandez-Gutierrez A, Majid S, Eberle AT, Choi AS, Sorkhdini P, Yang D, Yang A, Norbrun C, He C, Lee CM, Lee CG, Elias JA, Zhou Y. "Phospholipid scramblase-1 regulates innate type 2 inflammation in mouse lung via CRTH2-dependent mechanisms." Journal of Clinical Investigation, 2023. |
| Sun X, Nakajima E, Norbrun C, Sorkhdini P, Yang AX, Yang D, Ventetuolo CE, Braza J, Vang A, Aliotta J, Banerjee D, Pereira M, Baird G, Lu Q, Harrington EO, Rounds S, Lee CG, Yao H, Choudhary G, Klinger JR, Zhou Y. "Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension." JCI insight, vol. 7, no. 18, 2022. |
| Cao Y, Rudrakshala J, Williams R, Rodriguez S, Sorkhdini P, Yang AX, Mundy M, Yang D, Palmisciano A, Walsh T, Delcompare C, Caine T, Tomasi L, Shea BS, Zhou Y. "CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis." American Journal of Respiratory Cell and Molecular Biology, vol. 67, no. 2, 2022, pp. 201-214. |
| Jakaria, Md Golam, Sorkhdini, Parand, Yang, Dongqin, Zhou, Yang, Meenach, Samantha A. "Lung cell membrane-coated nanoparticles capable of enhanced internalization and translocation in pulmonary epithelial cells." International Journal of Pharmaceutics, vol. 613, 2022, pp. 121418. |
| Lee, Suh-Young, Lee, Chang-Min, Ma, Bing, Kamle, Suchitra, Elias, Jack A., Zhou, Yang, Lee, Chun Geun. "Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis." Frontiers in Pharmacology, vol. 13, 2022. |
| Ghumman, Moez, Dhamecha, Dinesh, Gonsalves, Andrea, Fortier, Lauren, Sorkhdini, Parand, Zhou, Yang, Menon, Jyothi U. "Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment." European Journal of Pharmaceutics and Biopharmaceutics, vol. 164, 2021, pp. 1-12. |
| Velázquez-Díaz, Pamela, Nakajima, Erika, Sorkhdini, Parand, Hernandez-Gutierrez, Ashley, Eberle, Adam, Yang, Dongqin, Zhou, Yang. "Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics." Frontiers in Pharmacology, vol. 12, 2021. |
| Byrum, Christine A., Korey, Christopher A., Jordan, Zachary, Zhou, Yang, Taylor, Sarah, Alfajardo, Joas, Delesalle, Veronique A. "Complete Genome Sequence of the Cluster F1 Mycobacteriophage KingMidas." Microbiology Resource Announcements, vol. 9, no. 7, 2020. |
| Rajagopal, Keshava, Bryant, Andrew J., Sahay, Sandeep, Wareing, Nancy, Zhou, Yang, Pandit, Lavannya M., Karmouty‐Quintana, Harry. "Idiopathic Pulmonary Fibrosis (IPF) and pulmonary hypertension: Heracles meets the Hydra." British Journal of Pharmacology, 2020. |
| Lee CM, He CH, Park JW, Lee JH, Kamle S, Ma B, Akosman B, Cotez R, Chen E, Zhou Y, Herzog EL, Ryu C, Peng X, Rosas IO, Poli S, Bostwick CF, Choi AM, Elias JA, Lee CG. "Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3." Life science alliance, vol. 2, no. 3, 2019. |
| Zhou Y, He CH, Yang DS, Nguyen T, Cao Y, Kamle S, Lee CM, Gochuico BR, Gahl WA, Shea BS, Lee CG, Elias JA. "Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease." The Journal of Immunology, vol. 200, no. 6, 2018, pp. 2140-2153. |
| Murray LA, Habiel DM, Hohmann M, Camelo A, Shang H, Zhou Y, Coelho AL, Peng X, Gulati M, Crestani B, Sleeman MA, Mustelin T, Moore MW, Ryu C, Osafo-Addo AD, Elias JA, Lee CG, Hu B, Herazo-Maya JD, Knight DA, Hogaboam CM, Herzog EL. "Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis." JCI insight, vol. 2, no. 16, 2017. |
| Lee CM, He CH, Nour AM, Zhou Y, Ma B, Park JW, Kim KH, Dela Cruz C, Sharma L, Nasr ML, Modis Y, Lee CG, Elias JA. "IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses." Nature Communications, vol. 7, 2016, pp. 12752. |
| Peng X, Moore M, Mathur A, Zhou Y, Sun H, Gan Y, Herazo-Maya JD, Kaminski N, Hu X, Pan H, Ryu C, Osafo-Addo A, Homer RJ, Feghali-Bostwick C, Fares WH, Gulati M, Hu B, Lee CG, Elias JA, Herzog EL. "Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis." The FASEB Journal, vol. 30, no. 12, 2016, pp. 4056-4070. |
| Zhou, Yang, He, Chuan Hua, Herzog, Erica L., Peng, Xueyan, Lee, Chang-Min, Nguyen, Tung H., Gulati, Mridu, Gochuico, Bernadette R., Gahl, William A., Slade, Martin L., Lee, Chun Geun, Elias, Jack A. "Chitinase 3–like–1 and its receptors in Hermansky-Pudlak syndrome–associated lung disease." Journal of Clinical Investigation, vol. 125, no. 8, 2015, pp. 3178-3192. |
| Kang, Min-Jong, Yoon, Chang Min, Kim, Bo Hye, Lee, Chang-Min, Zhou, Yang, Sauler, Maor, Homer, Rober, Dhamija, Anish, Boffa, Daniel, West, Andrew Phillip, Shadel, Gerald S., Ting, Jenny P., Tedrow, John R., Kaminski, Naftali, Kim, Woo Jin, Lee, Chun Geun, Oh, Yeon-Mok, Elias, Jack A. "Suppression of NLRX1 in chronic obstructive pulmonary disease." Journal of Clinical Investigation, vol. 125, no. 6, 2015, pp. 2458-2462. |
| Zhou, Y., Peng, H., Sun, H., Peng, X., Tang, C., Gan, Y., Chen, X., Mathur, A., Hu, B., Slade, M. D., Montgomery, R. R., Shaw, A. C., Homer, R. J., White, E. S., Lee, C.-M., Moore, M. W., Gulati, M., Geun Lee, C., Elias, J. A., Herzog, E. L. "Chitinase 3-Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis." Science Translational Medicine, vol. 6, no. 240, 2014, pp. 240ra76-240ra76. |
| Lee, Chang-Min, Park, Jin Wook, Cho, Won-Kyung, Zhou, Yang, Han, Boram, Yoon, Pyoung Oh, Chae, Jeiwook, Elias, Jack A, Lee, Chun Geun. "Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis." Korean J Intern Med, vol. 29, no. 3, 2014, pp. 281. |
| He, Chuan Hua, Lee, Chun Geun, Dela Cruz, Charles S., Lee, Chang-Min, Zhou, Yang, Ahangari, Farida, Ma, Bing, Herzog, Erica L., Rosenberg, Stephen A., Li, Yue, Nour, Adel M., Parikh, Chirag R., Schmidt, Insa, Modis, Yorgo, Cantley, Lloyd, Elias, Jack A. "Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2." Cell Reports, vol. 4, no. 4, 2013, pp. 830-841. |
| Zhou, Y., Lee, J.-Y., Lee, C.-M., Cho, W.-K., Kang, M.-J., Koff, J. L., Yoon, P.-O., Chae, J., Park, H.-O., Elias, J. A., Lee, C. G. "Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor- -induced Pulmonary Fibrosis." Journal of Biological Chemistry, vol. 287, no. 50, 2012, pp. 41991-42000. |
| Lee, C. G., Herzog, E. L., Ahangari, F., Zhou, Y., Gulati, M., Lee, C.-M., Peng, X., Feghali-Bostwick, C., Jimenez, S. A., Varga, J., Elias, J. A. "Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF- 1 Signaling." The Journal of Immunology, vol. 189, no. 5, 2012, pp. 2635-2644. |
| Zhou, Yang, Herzog, Erica, Gochuico, Bernadette R., Gahl, William, Lee, Chun G., Elias, Jack A. "Chitinase 3-Like 1 (CHI3L1) As A Biomarker And Therapeutic Target In The Pulmonary Fibrosis Of Hermansky-Pudlak Syndrome." A45. NON-IDIOPATHIC PULMONARY FIBROSIS INTERSTITIAL LUNG DISEASES, 2012. |
| Lee, Chun Geun, Dela Cruz, Charles S., Ma, Bing, Ahangari, Farida, Zhou, Yang, Halaban, Ruth, Sznol, Mario, Elias, Jack A. "Chitinase-like Proteins in Lung Injury, Repair, and Metastasis." Proc Am Thorac Soc, vol. 9, no. 2, 2012, pp. 57-61. |
| Carbonaro, D. A., Jin, X., Wang, X., Yu, X.-J., Rozengurt, N., Kaufman, M. L., Wang, X., Gjertson, D., Zhou, Y., Blackburn, M. R., Kohn, D. B. "Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction." Blood, vol. 120, no. 18, 2012, pp. 3677-3687. |
| Cho, Won-Kyung, Lee, Chang-Min, Zhou, Yang, Elias, Jack A., Lee, Chun Geun. "Role Of Arginase2 In TGF-Beta1-Induced Pulmonary Fibrosis." C68. OLD AND NEW PATHWAYS TO PULMONARY FIBROSIS, 2012. |
| Zhou, Yang, Lee, Chun G., Ahangari, Farida, Herzog, Erica, Elias, Jack A. "Chitotriosidase Contributes To The Pathogenesis Of Bleomycin-Induced Pulmonary Fibrosis." C32. STUDIES OF LUNG FIBROSIS, COPD AND AIRWAY REMODELING, 2011. |
| Ma, Wenbin, Ortiz-Quintero, Blanca, Rangel, Roberto, McKeller, Morgan R, Herrera-Rodriguez, Sara, Castillo, Eliseo F, Schluns, Kimberly S, Hall, Mary, Zhang, Huiyuan, Suh, Woong-Kyung, Okada, Hitoshi, Mak, Tak W, Zhou, Yang, Blackburn, Michael R, Martinez-Valdez, Hector. "Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice." Cell Res, vol. 21, no. 11, 2011, pp. 1564-1577. |
| Zhou, Yang, Cho, Won-Kyung, Lee, Jae-Young, Elias, Jack A., Lee, Chun G. "Role Of Amphiregulin In TGF-B1-Induced Pulmonary Fibrosis." C32. STUDIES OF LUNG FIBROSIS, COPD AND AIRWAY REMODELING, 2011. |
| Matsuura, Hiroshi, Hartl, Dominik, Kang, Min-Jong, Cruz, Charles S. Dela, Koller, Barbara, Chupp, Geoffrey L., Homer, Robert J., Zhou, Yang, Cho, Won-Kyung, Elias, Jack A., Lee, Chun Geun. "Role of Breast Regression Protein–39 in the Pathogenesis of Cigarette Smoke–Induced Inflammation and Emphysema." American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 6, 2011, pp. 777-786. |
| Zhou, Yang, Kang, Min-Jong, Silverman, Robert H., Lee, Chun G., Elias, Jack A. "Role Of Rnasel In Virus/Viral PAMP And Cigarette Smoke-Induced Inflammation And Remodeling." A101. MECHANISMS AND MODELS OF COPD, 2011. |
| He, Chuan H., Lee, Chun G., Ma, Bing, Cruz, Charles D., Liu, Wei, Zhou, Yang, Ahangari, Farida, Homer, Robert, Elias, Jack A. "YKL-40 Binds To And Signals Via IL-13 Receptor Alpha2 Using A Glycosylation-Dependent Mechanism." A65. MECHANISMS OF AIRWAY RESPONSE TO INJURY (RESPIRATORY VIRUSES, CIGARETTE SMOKE, AND ASTHMA), 2011. |
| Lu Q, Harrington EO, Newton J, Casserly B, Radin G, Warburton R, Zhou Y, Blackburn MR, Rounds S. "Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement." AJP: Lung Cellular and Molecular Physiology, vol. 298, no. 6, 2010, pp. L755-L767. |
| Zhou, Yang, Murthy, Jayasimha, Blackburn, Michael R. "Alterations In Adenosine Metabolism And Signaling In Patients With Chronic Obstructive Pulmonary Disease And Idiopathic Pulmonary Fibrosis." D48. INTERSTITIAL LUNG DISEASE: PATHOBIOLOGY, BIOMARKERS AND TREATMENT, 2010. |
| Zhou, Y., Schneider, D. J., Morschl, E., Song, L., Pedroza, M., Karmouty-Quintana, H., Le, T., Sun, C.-X., Blackburn, M. R. "Distinct Roles for the A2B Adenosine Receptor in Acute and Chronic Stages of Bleomycin-Induced Lung Injury." The Journal of Immunology, vol. 186, no. 2, 2010, pp. 1097-1106. |
| Schneider, D. J., Lindsay, J. C., Zhou, Y., Molina, J. G., Blackburn, M. R. "Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease." The FASEB Journal, vol. 24, no. 1, 2009, pp. 70-80. |
| Zhou, Yang, Schneider, Daniel J., Blackburn, Michael R. "Adenosine signaling and the regulation of chronic lung disease." Pharmacology & Therapeutics, vol. 123, no. 1, 2009, pp. 105-116. |
| Zhou, Y., Mohsenin, A., Morschl, E., Young, H. W. J., Molina, J. G., Ma, W., Sun, C.-X., Martinez-Valdez, H., Blackburn, M. R. "Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor." The Journal of Immunology, vol. 182, no. 12, 2009, pp. 8037-8046. |
My primary research interests are directed towards understanding the immunopathogenesis of lung injury and repair. I have interrogated the roles of adenosine signaling, EGFR signaling, and chitinase-like proteins in a variety of lung diseases including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. My future research plans are aimed at understanding 1) Role of innate immunity in the pathogenesis of fibrotic lung diseases, and nanoparticle delivery systems as therapeutics to treat related disorders; 2) Pathogenesis of abnormal pulmonary vascular remodeling and the development of pulmonary hypertension; 3) Innate Type 2 immune responses in normal pulmonary homeostasis and injury and repair; 4) Novel host genes and cellular pathways modulating respiratory viral infections. My long-range research goals are to identify the immune and cellular responses that mediate lung injury and repair responses and to identify specific molecular targets that can be targeted in the treatment of related disorders.
1) Role of innate immunity in the pathogenesis of fibrotic lung diseases, and nanoparticle delivery systems as therapeutics to treat related disorders.
Idiopathic pulmonary fibrosis (IPF) is a particularly deadly form of pulmonary fibrosis with unknown reason. Hermansky-Pudlak Syndrome (HPS) is a group of inherited autosomal recessive disorders caused by genetic mutations that alter the trafficking of lysosomal-related organelles/vesicles. In a subset of patients with HPS-1 and HPS-4, pulmonary fibrosis develops in the fourth or fifth decade of life, and is a major cause of morbidity and mortality. Experiments proposed in this project will define the cellular and molecular mechanisms of CHI3L1 receptor system, and whether CHI3L1 and its receptor systems are plausible targets to treat IPF and HPS-associated lung disease.
2) Pathogenesis of abnormal pulmonary vascular remodeling and the development of pulmonary hypertension.
Pulmonary fibrosis is characterized by chronic, progressive accumulation of scar tissue in the lung. Pulmonary hypertension (PH) is a common and deadly complication of pulmonary fibrosis with unknown causes and no effective treatment option. Experiments proposed in this project will determine whether CHI3L1 and its receptor systems are therapeutic targets to treat vascular remodeling and PH in pulmonary fibrosis.
3) Innate Type 2 immune responses in normal pulmonary homeostasis and injury and repair.
Type 2 immune responses are well documentedin normal homeostaticand immune responses in the lung. Recent studies have highlighted the importance of innate type 2 immune responses and innate lymphoid 2 cells (ILC2s) in disorders such as asthma, allergy, and pulmonary fibrosis. These studies will provide new and critical insights into biology and disease pathogenesis and identify novel targets that can be manipulated in attempts to control Type 2 inflammation in chronic diseases such as asthma.
4) Novel host genes and cellular pathways modulating respiratory viral infections.
Influenza A virus (IAV) is a single-stranded RNA virus that has caused several major pandemics in human history. Unfortunately, current anti-flu drugs targeting viral proteins have led to a significant increase in drug-resistant virus variants. Thus, it is important to understand host-viral protein interactions to design anti-flu drugs that target host factors. Our research may shed light on virus-host interactions and aid in the development of anti-flu drugs.
Ongoing Research Support
R01 HL146498 (Zhou) 03/22/20--02/28/25
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
Experiments proposed in this project will investigate CHI3L1 biology in pale ear mouse models of pulmonary fibrosis with phenotypes similar to human HPS disease. Targeting this pathway may benefit patients with HPS and other forms of pulmonary fibrosis including Idiopathic Pulmonary Fibrosis (IPF).
Role: Principal Investigator, $250,000 annual direct cost
P20 GM103652 (Meenach/Zhou) 06/01/21-05/31/23
Cardiopulmonary Vascular Biology COBRE Pilot Project: Development of Cell Membrane-Coated Nanoparticles for the Treatment of Pulmonary Fibrosis and Related Diseases
The objective of this proposal is to develop and validate novel particle-based therapeutics based on cell membrane-coated nanoparticle (CMCNP) for the attenuation of pulmonary fibrosis and related diseases.
Role: Co-Principal Investigator
Department of Defense PR211855 (Lee) 03/01/22-02/28/24
Bispecific targeting of CHI3L1 and PD-1/PD-L1 axis as a novel therapeutic strategy for idiopathic pulmonary fibrosis
This project aims to determine the specific role of CHI3L1 as a major driver of profibrotic microenvironment and to evaluate the therapeutic efficacy of a bispecific CHI3L1-PD-1 monoclonal antibody as an agent to block or reverse pulmonary fibrosis.
Role: Co-Investigator
P01 HL114501 (Choi) 04/01/21 – 04/30/26
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
This project will determine the differential roles of Chi3l1 and its receptors in COPD and IPF.
Role: Co-Investigator
T32 HL134625 (Harrington, Levy, Rounds, Zhou) 03/01/22-02/28/27
Brown Respiratory Research Training Program
The overall goal of this training program is to provide predoctoral candidates and postdoctoral fellows training in the pathobiology and/or outcomes, prevention, and epidemiology as it relates to pulmonary/ critical care/ sleep disorders.
Role: Multi-Principal Investigator
Completed Research Support
P20 GM 103652 (Zhou) 07/20/18-01/31/21
Cardiopulmonary Vascular Biology COBRE Project 3: CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
These studies will determine whether CHI3L1 and its receptor systems are therapeutic targets to treat vascular remodeling and PH in pulmonary fibrosis.
Role: Principal Investigator, $175,000 annual direct cost
U54 GM115677 (Zhou/Shea) 03/01/17 – 02/28/18
Chitinase 3-like 1 and its receptors in pulmonary fibrosis
Advance-CTR Pilot Project
Role: Principal Investigator
5P20 GM 103652-02 (Zhou) 1/1/15 – 6/30/15
NIH/NIGMS
Chitinase 3-like-1 in Pulmonary Hypertension Associated with Interstitial Lung Disease
Cardiopulmonary Vascular Biology Cobre Pilot Project
Role: Principal Investigator
American Thoracic Society (Zhou) 11/01/2011 - 10/31/2014
Chitinase-3 Like 1 as a Biomarker and Therapeutic Target in Hermansky-Pudlak Syndrome Associated Pulmonary Fibrosis
Role: Principal Investigator
1 UH2 HL 123876-01 (Chupp/Elias) 07/01/14 – 06/30/19
Pre-Clinical Development of Novel Anti-YKL-40 Biologic to Treat Severe Asthma
In this proposal, our multidisciplinary team in translational research, genomics, drug development, and immunology will complete the pre-clinical development of humanized monoclonal antibodies against YKL-40.
Role: Co-Investigator
1U01 HL 108638-01 (Elias) 7/1/11 – 6/30/16
NIH / NHLBI
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
This grant is designed to evaluate circulating YKL-40 as a biomarker for disease progression in IPF and urinary YKL-40 as a predictor of delayed graft function after renal transplantation. These studies will also evaluate the utility of YKL-40 as a therapeutic target in both disorders.
Role: Co-Investigator
| Year | Degree | Institution |
|---|---|---|
| 2010 | PhD | University of Texas Health Science Center |
| 2005 | BS | Nanjing University |
American Thoracic Society Abstract Scholarship Award 2013 and 2014
American Thoracic Society/Hermansky-Pudlak Syndrome Network Research Award 2011
President’s Research Scholarship, The University of Texas Health Science Center 2010
The University of Texas Houston Medical School Dean’s Research Award 2009
Keystone Symposia Scholarship, Keystone Symposia of Asthma and Fibrosis 2009
American Thoracic Society Genentech/Novartis Award 2008
| Name | Title |
|---|---|
| Elias, Jack | Warren Alpert Foundation Professor of Translational Science, Professor of Molecular Biology, Cell Biology and Biochemistry, Professor of Medicine |
| Harrington, Elizabeth | Associate Dean for Graduate Studies, Professor of Medicine |
| Klinger, James | Professor of Medicine |
| Lee, Chun Geun | Professor of Molecular Microbiology and Immunology (Research) |
| Rounds, Sharon | Associate Dean for Translational Science, Professor of Medicine, Professor of Pathology and Laboratory Medicine |
| Shea, Barry | Assistant Professor of Medicine |
| Ventetuolo, Corey | Associate Professor of Medicine, Associate Professor of Health Services, Policy and Practice |
American Thoracic Society
Hermansky-Pudlak Syndrome Network
| BIOL 0190R - Phage Hunters, Part I |
| BIOL 0190S - Phage Hunters, Part II |
